School of Medicine
Showing 561-570 of 5,039 Results
-
Erica P. Cahill MD, MSCP
Clinical Associate Professor, Obstetrics & Gynecology
Current Research and Scholarly Interestsreproductive and sexual health care and education
-
Weidong Cai
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMy research program investigates the neurobiological basis of cognitive dysfunction across the lifespan, focusing on two critical populations: children with neurodevelopmental disorders (e.g., ADHD) and elders with neurodegenerative conditions (e.g., Parkinson’s disease). By employing a highly interdisciplinary approach that integrates cognitive science, advanced functional neuroimaging, and computational modeling, I aim to delineate the neurocognitive processes governing both typical and atypical brain development and aging. The ultimate goal is to advance our understanding of the factors contributing to cognitive deficits and translate these findings into improved diagnostic tools and precision treatment strategies.
-
Alison Callahan
Research Engineer, Computational Medicine
BioAlison Callahan is a Research Scientist in the Division of Computational Medicine and a Data Scientist on the Stanford Health Care Data Science team. Her current research uses informatics and artificial intelligence to improve rare disease screening. Her work in the SHC Data Science team focuses on developing and implementing methods to assess and identify high value applications of AI in healthcare settings.
Alison holds a master’s degree in information studies from the University of Toronto, and a doctorate in bioinformatics from Carleton University. She completed her postdoctoral training at Stanford. -
Michele Calos
Professor of Genetics, Emerita
Current Research and Scholarly InterestsMy lab is developing innovative gene and stem cell therapies for genetic diseases, with a focus on gene therapy and regenerative medicine.
We have created novel methods for inserting therapeutic genes into the chromosomes at specific places by using homologous recombination and recombinase enzymes.
We are working on 3 forms of muscular dystrophy.
We created induced pluripotent stem cells from patient fibroblasts, added therapeutic genes, differentiated, and engrafted the cells.
